RARE

16.6303.43%
HH

Howard Horn

Executive VP of Corporate Strategy & CFO

Mr. Howard Horn is Chief Financial officer of Ultragenyx Pharmaceutical Inc since October 16, 2023 and serves as its Executive Vice President of Corporate Strategy and served as its Executive Vice President since October 16, 2023. He is responsible for leading the finance, accounting, corporate strategy and investor relations functions. He served as Chief Financial Officer and Secretary of Vir Biotechnology, Inc. since March 2017 until March 27, 2023 and served as its Executive Vice President since March 2022 until March 27, 2023. Prior to joining, Mr. Horn served at Biogen as its Vice President, Business Planning from June 2015 to October 2016, where he led Biogen’s resource allocation processes across all functions and regions. From October 2013 to June 2015, Mr. Horn served as Biogen Vice President, Strategic Corporate Finance. Mr. Horn served as Equity Analyst at UBS Investment Bank, Research Division. Previously, he led the Financial Planning and Corporate Finance functions at Biogen. Prior to joining Biogen, he held positions of increasing responsibility and was focused on the life sciences as a consultant with McKinsey & Company from 2004 to 2013 and as an equity research analyst in the Life Sciences group at UBS Group AG, from 1999 to 2002. Mr. Horn holds an M.B.A from the Wharton School of the University of Pennsylvania and a B.A in Economics from Princeton University.

Positions